Beam one-ups Wave as both show promise of genetic editing for AATD

BioSpace

While both Beam Therapeutics and Wave Life Sciences touted notable biomarker benefits for their respective alpha-1 antitrypsin deficiency assets,...

pharminent May 20, 2026 (Last updated: May 21, 2026)

BioSpace

While both Beam Therapeutics and Wave Life Sciences touted notable biomarker benefits for their respective alpha-1 antitrypsin deficiency assets,…

Related Stories